Photocure ASA (PHO.OL)
Photocure ASA, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
54.30+0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-14.1%
The outlook
Photocure ASA currently reads as neutral based on strong buy — 1.3 avg of 3 analysts, below its 50- & 200-day averages, 13% of the way from its 52-week low to high, avg target +52% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 3 analysts
Price trendBelow its 50- & 200-day averages
52-week range13% of the way from its 52-week low to high
Price targetAvg target +52% vs current price
Analyst price target
~12-month · 3 analysts82.33average target+51.6% vs now
Now 54.30
Low 75.00High 90.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.44B
52-wk high
79.80
52-wk low
50.50
50-day avg
59.57
200-day avg
63.38
Trailing P/E
18.7